FDAFDA · Food and drugs·Recall number D-0746-2022
Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx Only, Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA, by Patheon Puerto Rico, Inc. Manati, Puerto Rico, 00674 Bottle (NDC 0006-0575-02), Carton (NDC 0006-0575-03)
Published April 13, 2022 · Recall initiated: March 31, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign substance: Presence of stainless steel particulates in tablets.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- JANUMET
- Manufacturer
- MERCK SHARP & DOHME CORP
- Distributor
- Nationwide in the USA
- UPC
- 0300060575617
- Lot
- Lot: U015824, Exp. 09/22.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.